Related Experiment Video
Updated: Feb 15, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Measles virus: Background and oncolytic virotherapy
Sankhajit Bhattacharjee1, Pramod Kumar Yadava1
1Applied Molecular Biology Laboratory, School of life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Abstract:
Measles is a highly transmissible disease caused by measles virus and remains a major cause of child mortality in developing countries. Measles virus nucleoprotein (N) encapsidates the RNA genome of the virus for providing protection from host cell endonucleases and for specific recognition of viral RNA as template for transcription and replication. This protein is over-expressed at the time of viral replication. The C-terminal of N protein is intrinsically disordered, which enables this protein to interact with several host cell proteins. It was previously proved in our laboratory that N expressing human cancerous cells undergo programmed cell death because of reactive oxygen species (ROS) generation as well as Caspase 3 activation. The phosphoprotein (P) along with N protein enclosed viral genomic RNA forming a ribonucleoprotein complex (RNP). It also establishes interaction with the large protein (L) i.e. viral RNA dependent RNA polymerase to ensure viral replication within host cells. The host cell receptors of this virus are CD46, SLAM/CD150 and PVRL4. Measles virus is latently oncotropic in nature and possesses oncolytic property by syncytia formation. We try to highlight the application of this property in developing a virotherapeutic vehicle.
Insights
Measles virus nucleoprotein induces cancer cell death via reactive oxygen species and Caspase 3 activation. This oncotropic virus
Area of Science:
- Virology
- Molecular Biology
- Cancer Research
Background:
- Measles virus (MeV) is a significant cause of childhood mortality globally.
- The MeV nucleoprotein (N) is crucial for viral RNA encapsidation, protection, and replication.
- The intrinsically disordered C-terminus of MeV N protein facilitates interactions with host cell proteins.
Purpose of the Study:
- To investigate the role of MeV nucleoprotein in inducing programmed cell death in human cancer cells.
- To explore the potential of MeV's oncolytic properties for developing virotherapeutic strategies.
Main Methods:
- Analysis of programmed cell death induction in N protein-expressing human cancerous cells.
- Assessment of reactive oxygen species (ROS) generation and Caspase 3 activation.
- Review of MeV's interaction with host cell receptors (CD46, SLAM/CD150, PVRL4) and its oncolytic potential.
Main Results:
- Measles virus nucleoprotein expression triggers programmed cell death in human cancer cells.
- This cell death is mediated by reactive oxygen species generation and Caspase 3 activation.
- Measles virus exhibits oncotropism and oncolytic activity through syncytia formation.
Conclusions:
- Measles virus nucleoprotein plays a key role in inducing cancer cell apoptosis.
- The oncolytic properties of measles virus present a promising avenue for developing novel virotherapeutics.
- Further research into MeV-based virotherapy could lead to new cancer treatment strategies.
Related Concept Videos
What are Viruses?
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes

